Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

GETTING your body moving is a key way to keep dementia at bay. But lowering your risk of the brain-robbing disease might not ...

Though Alzheimer's disease is often described as a buildup of proteins in the brain in the form of plaques and tangles, a new ...

Though Alzheimer’s disease is often described as a buildup of proteins in the brain in the form of plaques and tangles, a new ...

Discover the breakthrough Alzheimer's test that measures tau tangles in blood, simplifying Alzheimer's diagnosis and ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

BOSTON - NeuroNOS, a subsidiary of Beyond Air (NASDAQ:XAIR), has made a significant breakthrough in Alzheimer’s disease (AD) research, as detailed in a recent publication in the peer-reviewed ...

Age-related neurodegenerative disorders — motor neuron diseases, demyelinating diseases, Alzheimer’s disease, and other proteinopathies — are at an ‘inflection point.’ ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...

Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a newly published study, ...

BOSTON - NeuroNOS, a subsidiary of Beyond Air (NASDAQ:XAIR), has made a significant breakthrough in Alzheimer’s disease (AD) research, as detailed in a recent publication in the peer-reviewed journal ...